Advertisement
Virtual house calls by neurologists may be of great interest to and provide substantial convenience for patients with Parkinson's disease

Telehealth Feasible for Parkinson’s Care

0
Online visits saved patients more than two hours and 100 miles of driving, researchers found
Radioiodine therapy for thyroid cancer is not associated with increased risk of stroke

Radioiodine Therapy for Thyroid Cancer Doesn’t Up Stroke Risk

0
I-131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke
There is no significant difference in cognitive function for patients treated with evolocumab or placebo added to statin therapy

Evolocumab Doesn’t Affect Cognition When Added to Statins

0
No significant between-group difference for patients receiving evolocumab or placebo added to statins
Within a cohort of patients insured through TRICARE

Opioid Rx Frequently Issued for Nonspecific, Spinal Conditions

0
Spine, orthopedic disorders most prominent among categories of conditions linked to initial opioid Rx
Lifetime costs of care are substantially increased for individuals with dementia

Families Shoulder Majority of Costs Related to Dementia Care

0
Reducing functional decline or behavioral and psychological symptoms leads to lower lifetime costs
Enhancing physical activity level and function can decrease the fear of falling among elderly patients

Increasing Physical Activity, Function Can Decrease Fall Fears

0
Activities of daily living and mobility among predictors of fear of falling in geriatric patients
During the past two decades

Increase in Survival Without Severe Disability for Preemies

0
However, children born preterm still have high risk for developmental delay
De novo KCNB1 missense and loss-of-function variants are associated with neurodevelopmental disorders

Phenotype Varies for Presumed Pathogenic Variants in KCNB1

0
De novo mutations in KCNB1 associated with variable neurodevelopmental disorder
Adoption of specialty access standards has not improved access to specialists

Specialist Access No Better With Adoption of Access Standards

0
No notable improvement in timely access to specialty services following implementation of standards
Many studies used to support U.S. Food and Drug Administration approval of high-risk medical device modifications are not controlled; and efficacy of drugs granted accelerated approval is often confirmed three years after approval

Studies Used for FDA Approval of Device Changes Often Low Quality

0
And, efficacy of drugs granted accelerated approval often confirmed only years after approval